VAXELIS DTPa5-HepB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringe

产品概览

About VAXELIS DTPa5-HepB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringe

VAXELIS DTPa5-HepB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringe is a medicine supplied as a suspension for injection in a 0.5 mL pre-filled syringe. It contains antigenic components associated with protection against diphtheria, tetanus, pertussis, poliovirus infection, Haemophilus influenzae type B infection, and hepatitis B infection. The vaccine combines several components in one product, including toxoids, purified pertussis components, poliovirus, Haemophilus influenzae type B polyribose ribitol phosphate, and hepatitis B surface antigen.

Key Benefits & Uses

• Provides vaccine components for immunisation against diphtheria and tetanus.
• Includes components for immunisation against pertussis, poliovirus infection, and Haemophilus influenzae type B infection.
• Contains hepatitis B surface antigen for immunisation against hepatitis B infection.

Active Ingredient & Action

The active ingredients are tetanus toxoid, diphtheria toxoid, poliovirus, pertussis fimbriae 2 + 3, Haemophilus influenza type B polyribose ribitol phosphate, pertussis toxoid, pertussis filamentous haemagglutinin, hepatitis B surface antigen, and pertactin. These vaccine antigens are presented to the immune system to support development of an immune response.

Important Notes

VAXELIS DTPa5-HepB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringe should be used according to official prescribing information and an appropriate immunisation schedule. The supplied facts do not specify inactive ingredients, contraindications, or administration instructions. Consult a qualified healthcare professional for product-specific guidance.